Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples

A panel of 245 clinical samples with known treatment histories was retrospectively evaluated for cross-resistance to new protease inhibitors (PI). Samples with resistance to previously approved PI displayed high cross-resistance to atazanavir, whereas cross-resistance to amprenavir was considerably...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	AIDS (London) 2003-05, Vol.17 (8), p.1258-1261
Hauptverfasser:	Schnell, T, Schmidt, B, Moschik, G, Thein, C, Paatz, C, Korn, K, Walter, H
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!